Selectquote earnings beat by $0.14, revenue topped estimates

Selectquote (NYSE: SLQT) reported a stronger-than-anticipated fourth quarter, with EPS of $-0.020 significantly beating the $-0.160 analyst estimate and revenue of $345.1M exceeding consensus. The company also issued robust FY2026 revenue guidance of $1.650B-$1.750B, well above the $1.520B analyst consensus, signaling a positive outlook. Despite these strong financial results, SLQT's stock has experienced substantial declines, falling over 14% in the last three months and 47% over the past year, highlighting a potential disconnect between recent operational performance and market valuation.

Analysis

Selectquote (SLQT) reported a significant fourth-quarter earnings beat with an EPS of $-0.020, substantially better than the analyst consensus of $-0.160, alongside a marginal revenue beat at $345.1M. More notably, the company issued highly optimistic fiscal year 2026 revenue guidance of $1.650B to $1.750B, comfortably exceeding the consensus estimate of $1.520B. This strong operational performance and positive forward outlook stand in stark contrast to the stock's severe underperformance, having declined 14.08% over the last three months and 47.11% over the past year. While an InvestingPro financial health score of "good performance" supports the fundamental picture, the presence of both positive and negative EPS revisions in the last 90 days indicates a divided analyst community, suggesting that market skepticism may persist despite the encouraging results and guidance.

Key Decisions for Investors

• Given the significant disconnect between the strong Q4 results, robust FY2026 guidance, and the stock's recent severe price decline, investors could consider the current valuation a potential turnaround opportunity.
• Caution is warranted due to the stock's deep 12-month downtrend and mixed analyst revisions; it is critical to watch for confirmation of a new positive trend and improved sentiment from the broader analyst community.
• Investors should prioritize monitoring the company's execution against its ambitious long-term revenue targets in subsequent quarters, as this will be the key validation for the bullish thesis.